Published in TB and Outbreaks Week, June 14th, 1999
Contracted through blood transfusions, contaminated needles, and sexual contact, HCV is a growing threat in Japan, where more than 2.5 million Japanese suffer from this blood-borne viral infection. RDKK has marketing clearance from the Japan Ministry of Health for the Roche AMPLICOR HCV test and Version 2.0 AMPLICOR HCV MONITOR...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week